8 March 2018Big Pharma

EU shoots down UK’s EMA membership post-Brexit

European Council president Donald Tusk appears to have shot down the possibility of the UK remaining part of some EU agencies, including the European Medicines Agency (EMA), after Brexit.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Theresa May explores possibility of EMA membership post-Brexit

5 March 2018 The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit.

Parliament votes for UK to stay in EMA

23 July 2018 The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

More on this story

Theresa May explores possibility of EMA membership post-Brexit

5 March 2018 The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit.

Parliament votes for UK to stay in EMA

23 July 2018 The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

More on this story

Theresa May explores possibility of EMA membership post-Brexit

5 March 2018 The UK’s Prime Minister has revealed that the UK would be willing to remain part of the European Medicines Agency after Brexit.

Parliament votes for UK to stay in EMA

23 July 2018 The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency.

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility